Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples

    Posted byNilogen IT
    RESOURCES | PRESENTATIONS, PUBLICATIONS, AND POSTERS | Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples
     

    Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples

    Nov 13, 2019

    Vijayendra Agrawal Ph.D. , Mibel Pabon, Ph.D. , Tina Pastoor, M.S , Jenny Kreahling, Ph.D. and Soner Altiok, M.D., Ph.D.

    DOWNLOAD poster

    OTHER PUBLICATIONS

    Impact of Combined Blockade of PD1 and Activation of CD137 on Tumor Infiltration and Tumor Cell Killing Efficacy of Tumor Infiltrating Lymphocytes (TILs) in an Ex Vivo Autologous 3D Tumoroid Model of NSCLC Patient Samples.

    Impact of Combined Blockade of PD1 and Activation of CD137 on Tumor Infiltration and Tumor Cell Killing Efficacy of Tumor Infiltrating Lymphocytes (TILs) in an Ex Vivo Autologous 3D Tumoroid Model of NSCLC Patient Samples.

    Melba Marie Page, Ph.D., Vijayendra Agrawal Ph.D., Mibe...

    Nov 13, 2019

    Functional 3D-plEX Quantitative Multiplex Immunofluorescence Platform to Assess Immuno-oncology Drug Impact on Tumor Microenvironment in Ex Vivo Treated Intact 3D-tumor Organoids of Fresh Patient Tumor Tissue

    Functional 3D-plEX Quantitative Multiplex Immunofluorescence Platform to Assess Immuno-oncology Drug Impact on Tumor Microenvironment in Ex Vivo Treated Intact 3D-tumor Organoids of Fresh Patient Tumor Tissue

    Vijayendra Agrawal Ph.D., Mibel Pabón, Ph.D. , Tina Pa...

    Nov 13, 2019

    A Patient-driven Ex Vivo 3D Tumor Organoid Model to Assess Efficacy of Tumor Infiltrating T-cell Adoptive Cell Therapy

    A Patient-driven Ex Vivo 3D Tumor Organoid Model to Assess Efficacy of Tumor Infiltrating T-cell Adoptive Cell Therapy

    Mibel Pabón, Ph.D. , Vijayendra Agrawal Ph.D., Tina Pa...

    Nov 13, 2019

    SHOW MORE